Form D · Pharmaceuticals
SiteOne Therapeutics, Inc.
Bozeman, MT · CIK 0001647628
Offering snapshot reported Feb 14, 2017 · SEC filing
- Reported sold
- $14.9M Offering amount: $15.1M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 21, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 14, 2017 | Initial | $14,862,622 | No comparison | 19 | SEC filing |
| Jul 16, 2015 | Initial | $1,278,358 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-280621
Source: Form D, filed Feb 14, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stan E. Abel | Director, Executive |
| Justin Du Bois | Director |
| George Miljanich | Executive |
| John Mulcahy | Executive |
| Rick Orr | Director |
| Will Price | Director |
| Lowell Sears | Director |
| Joseph Zakrzewski | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
203 Enterprise Blvd. Suite 3
Bozeman, MT, 59718
Bozeman, MT, 59718